Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up.
Gitta BoonsTimon VandammeLaura MariënWillem LybaertGeert RoeyenTim RondouKonstantinos PapadimitriouKatrien JanssensBart Op de BeeckMarc SimoensWim DemeyIsabel DeroGuy Van CampMarc PeetersKen Op de BeeckPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Sequential genome-wide profiling of plasma cfDNA is a novel, noninvasive biomarker with high specificity for diagnosis, prognosis, and follow-up in metastatic NENs.